Clinical Trial

The Immune Response to Stroke

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2022 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.
Trial Details
NCT Number NCT05277129
Lead Sponsor University of Oslo
Conditions Stroke, Acute, Dementia
Enrollment 40 participants
Start Date 2021-06-24
Primary Completion 2025-12-31 (estimated)
Study Completion 2029-06-06 (estimated)
Updated on ClinicalTrials.gov 2022-03-14